BDBM755200 US20250213705, Compound 94

SMILES CC(=O)NCCOCCOCCOCCC(=O)N[C@@H](Cc1ccc(C(=O)O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 755200   

TargetGlutamate carboxypeptidase 2(Human)
Bright Peak Therapeutics

US Patent
LigandPNGBDBM755200(US20250213705, Compound 94)
Affinity DataKi:  0.0130nMAssay Description:Prepare a working solution of 100 μM Amplex® Red reagent containing 0.25 U/mL HRP, 0.08 U/mL L-glutamate oxidase, 0.5 U/mL 1-glutamate-pyruvate trans...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bright Peak Therapeutics

US Patent
LigandPNGBDBM755200(US20250213705, Compound 94)
Affinity DataIC50: 1.87nMAssay Description:Prepare a working solution of 100 μM Amplex® Red reagent containing 0.25 U/mL HRP, 0.08 U/mL L-glutamate oxidase, 0.5 U/mL 1-glutamate-pyruvate trans...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bright Peak Therapeutics

US Patent
LigandPNGBDBM755200(US20250213705, Compound 94)
Affinity DataKd:  2.33nMAssay Description:The interaction of PSMA-binding variants with human FOLH1 was measured with Surface Plasmon Resonance (SPR) technology. Biotinylated FOLH1 was captur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/22/2025
Entry Details
US Patent